Css LLC Bio N Tech Se Call Options Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $296,075 - $465,125	2,500 New	2,500 $375,000
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $369,750 - $558,720	3,000 Added 42.86%	10,000 $1.49 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $101,000 - $185,480	800 Added 12.9%	7,000 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $761,941 - $1.65 Million	3,700 Added 148.0%	6,200 $1.69 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $283,300 - $603,725	2,500 New	2,500 $560,000

Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $814,351 - $1.45 Million	-11,200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$57.81 - $104.17 $358,422 - $645,854	6,200 Added 124.0%	11,200 $776,000
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $192,900 - $333,700	5,000 New	5,000 $334,000

328

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $20.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.